Skip to main content
logo
Heidelberg Pharma AG (ETR:HPHA)
Germany flag Germany · Delayed Price · Currency is EUR
2.540
-0.060 (-2.31%)
Aug 5, 2026, 5:35 PM CET

Heidelberg Pharma AG Ratios and Metrics

Millions EUR. Fiscal year is Dec - Nov.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Market Capitalization
119136112129266177
Market Cap Growth
-40.56%21.70%-13.03%-51.73%50.53%9.59%
Enterprise Value
941137584272164
Last Close Price
2.542.912.402.765.725.18

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
PS Ratio
15.9693.4116.3313.0514.3987.04
PB Ratio
-8.36-12.473.622.614.0026.43
P/TBV Ratio
--5.083.184.62-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
EV/Sales Ratio
12.6277.8011.028.4914.6880.41

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Debt / Equity Ratio
0.00-0.010.010.120.241.59
Net Debt / Equity Ratio
1.751.36-0.95-0.76-0.980.67
Net Debt / EBITDA Ratio
0.680.311.391.403.69-0.18
Net Debt / FCF Ratio
1.000.470.971.096.92-0.16
Asset Turnover
0.140.030.110.120.300.10
Inventory Turnover
0.080.020.160.431.769.66
Quick Ratio
3.781.514.402.312.960.51
Current Ratio
5.292.535.952.863.150.60
Return on Equity (ROE)
-1539.85%-423.92%-48.33%-35.09%-53.73%-267.02%
Return on Assets (ROA)
-42.58%-61.88%-20.82%-20.14%-18.70%-78.14%
Return on Capital Employed (ROCE)
-93.70%-181.70%-41.40%-54.50%-25.20%-380.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Earnings Yield
-27.86%-31.06%-17.33%-15.82%-7.39%-14.77%
FCF Yield
-20.92%-23.31%-26.86%-26.91%-3.55%-15.74%
Buyback Yield / Dilution
-0.33%-0.14%-0.02%-25.14%-14.56%-8.72%